Canada markets close in 31 minutes

NuGen Medical Devices Inc. (NGMD.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1300+0.0150 (+13.04%)
As of 09:30AM EST. Market open.
Full screen
Previous Close0.1150
Open0.1300
Bid0.1150 x N/A
Ask0.1200 x N/A
Day's Range0.1300 - 0.1300
52 Week Range0.0350 - 0.3050
Volume3,200
Avg. Volume247,210
Market Cap25.256M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0800
Earnings DateNov 29, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    InsuJet(TM) Registered as a Medical Device in Mexico

    Second Bulk Sale for InsuJet(TM) Now Paid in Full Toronto, Ontario--(Newsfile Corp. - November 13, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce the Mexican government has completed the registration of NuGen's needle-free InsuJet™ injection device for sale throughout the country as a medical device.In May 2023, NuGen received its first bulk purchase order from Science-Link Trading SAPI de CV ("Science-Link"), a health and wellness company in ..

  • Newsfile

    Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical

    www.insujet.com - a diabetic e-commerce store Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the official launch on Shopify of its diabetic's lifestyle subscription business at www.insujet.com offering diabetics the ability to purchase our revolutionary needle-free InsuJet™ device and consumables online, direct to

  • Newsfile

    MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen

    Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that Mr. Ian Heynen has commenced his role as the Company's new Chief Executive Officer focusing his attention on fully commercializing the Company with sales and manufacturing capabilities that drive growth while effectively managing the P&L. Bio of Mr. Ian Heynen:Mr.